Medtronic buys Cardiocom for $200M

Candace Stuart | | Cardiovascular Business | Patient Care

Medtronic will pay $200 million to acquire a telehealth company whose products will be applied in the heart failure setting.

Minneapolis-based Medtronic said it completed its acquisition of Cardiocom, a company that provides products and services for remote monitoring and management of patients with chronic diseases. Medtronic described the acquisition as an opportunity to extend its reach into healthcare services, initially with a focus on heart failure.

Omar Ishrak, chairman and CEO of Medtronic, said the deal complements Medtronic’s plans to expand into broader healthcare services. The heart failure initiative is expected to integrate devices and software with the goal of improving care coordination and patient outcomes while lowering costs.

Candace Stuart, Contributor

Related Content

ACC offers practical approaches for arrhythmia monitoring after stroke
FDA and Boston Scientific issue urgent alert about pacemaker failures following 2 deaths
Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.